Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
4 weeks ago · TechCrunch
Global
& newspaper;
Read Full Article →
Sourced From
TechCrunch
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Source: TechCrunch — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: TechCrunch — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.